Cytokines and autoimmune disease (Q37433285)

20 August 2017

1 reference

title

Cytokines and autoimmune disease (English)

1 reference

20 August 2017

1 reference

1

Kroemer G

1 reference

20 August 2017

Martínez C

2

1 reference

20 August 2017

publication date

1 December 1991

1 reference

Clinical Immunology and Immunopathology

20 August 2017

published in

1 reference

20 August 2017

volume

61

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

275-295

1 reference

Cytokines: coordinators of immune and inflammatory responses

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukins and the immune system 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

1 reference

7 January 2021

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Cytokine assays: role in evaluation of the pathogenesis of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

The effect of tumor necrosis factor alpha and gamma-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin-2 receptor levels indicating relapse in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Elevated serum interleukin-2 levels in chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Production of tumor necrosis factor/cachectin by peripheral blood mononuclear cells in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Analysis of restriction fragment length polymorphism in lymphokine genes of normal and autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Quantitation of mRNA by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Ontogeny of T cell development in avian scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Are Ly1 B cells responsible for the IL2-hyperresponsiveness of B cells in autoimmune-prone NZB x NZW F1 mice?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

B cell hyperresponsiveness to interleukin 2 and the age-associated decline in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Physiology and pathology of an immunoendocrine feedback loop

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

How many genes code for organ-specific autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Soluble interleukin-2 receptors in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Biological and clinical aspects of interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Acquired defect in interleukin-2 production in patients with type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

T lymphocyte subsets, suppressor and contrasuppressor cell functions, and production of interleukin-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Immunogenetic analysis of spontaneous autoimmune thyroiditis of obese strain chickens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

IgG1 plasmacytosis in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interferon alfa therapy in severe unresponsive subacute cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin 1 enhances the development of spontaneous arthritis in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Therapy for systemic juvenile rheumatoid arthritis with gamma-interferon: a pilot study of nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

T lymphocyte-derived colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

Interleukin-1 and its biologically related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980001-7

7 January 2021

10.1016/S0090-1229(05)80001-7

Identifiers

DOI

1 reference

20 August 2017

1 reference